Project Details
Description
A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI 907828) treatment in patients with treatment-na??ve or pre-treated advanced dedifferentiated liposarcoma
Status | Finished |
---|---|
Effective start/end date | 8/21/24 → 11/26/24 |
Funding
- BOEHRINGER INGELHEIM VETMEDICA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.